LONDON (Reuters) Jul 26
The European Medicines Evaluation Agency said on Thursday GlaxoSmithKline’s anti-smoking drug Zyban had cleared a safety review.
The agency was asked by Germany to review the drug after reports that a number of people using it to quit smoking had died
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!